Vycor Medical (VYCO) EBIT Margin (2022 - 2023)
Vycor Medical (VYCO) has disclosed EBIT Margin for 6 consecutive years, with 8.26% as the latest value for Q3 2023.
- Quarterly EBIT Margin rose 2015.0% to 8.26% in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 1.41% through Sep 2023, up 5634.0% year-over-year, with the annual reading at 231.82% for FY2012, 24458.0% up from the prior year.
- EBIT Margin for Q3 2023 was 8.26% at Vycor Medical, down from 19.99% in the prior quarter.
- The five-year high for EBIT Margin was 19.99% in Q2 2023, with the low at 28.4% in Q3 2022.